Q32 Bio Inc expected to post a loss of 98 cents a share - Earnings Preview

Q32 Bio

04/08/2025 13:55

Q32 Bio Inc QTTB.OQ QTTB.O is expected to  show no change in quarterly revenue when it reports  results on August 6 (estimated) for the period ending June 30 2025

​LSEG's mean analyst estimate for Q32 Bio Inc is for a loss of 98 cents per share.

The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 1 "strong buy" or "buy," 3 "hold" and no "sell" or "strong sell."

The mean earnings estimate of analysts was unchanged in the last three months. ​

Wall Street's median 12-month price target for Q32 Bio Inc is $8.00, about 75% above its last closing price of $2.00

Previous quarterly performance (using preferred earnings measure in US dollars). ​

QUARTER ENDING
STARMINESMARTESTIMATE®
LSEG IBES ESTIMATE
ACTUAL
BEAT, MET, MISSED
SURPRISE %
Mar. 31 2025
-1.20
-1.23
-0.90
Beat
26.8
Dec. 31 2025
-1.50
-1.51
-1.16
Beat
23.2
Sep. 30 2024
-1.40
-1.40
-1.46
Missed
-4​
Jun. 30 2024
-1.05
-1.04
-1.42
Missed
-36.2
​​Mar. 31 2024
-1.42
-2.32
-14.95
Missed
-543.5
Dec. 31 2023
-5.40
-5.40
-5.04
Beat
6.7​
Sep. 30 2023
-7.56
-7.56
-10.26
Missed
-35.7
Jun. 30 2023
-8.94
-8.55
-10.98
Missed
-28.4

This summary was machine generated August 4 at 12:55 GMT.  All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)